Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study

BACKGROUND: India is home to 60% of the total global visceral leishmaniasis (VL) population. Use of long-term oral (e.g. miltefosine) and parenteral drugs, considered the mainstay for treatment of VL, is now faced with increased resistance, decreased efficacy, low compliance and safety issues. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundar, Shyam, Pandey, Krishna, Thakur, Chandreshwar Prasad, Jha, Tara Kant, Das, Vidya Nand Ravi, Verma, Neena, Lal, Chandra Shekhar, Verma, Deepak, Alam, Shahnawaz, Das, Pradeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169371/
https://www.ncbi.nlm.nih.gov/pubmed/25233346
http://dx.doi.org/10.1371/journal.pntd.0003169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169371/
https://www.ncbi.nlm.nih.gov/pubmed/25233346
http://dx.doi.org/10.1371/journal.pntd.0003169

Ejemplares similares